# Safety and Efficacy of CryoCor™ Cryoablation for PAF

> **NCT00231296** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 174 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Cardiac CryoCor Cryoablation System
- **DRUG:** Medical management

## Key facts

- **NCT ID:** NCT00231296
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231296, "Safety and Efficacy of CryoCor™ Cryoablation for PAF". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00231296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*